{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T11:30:53Z","timestamp":1725622253434},"publisher-location":"Boston, MA","reference-count":10,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461372035"},{"type":"electronic","value":"9781461548577"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-1-4615-4857-7_81","type":"book-chapter","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T15:44:47Z","timestamp":1318952687000},"page":"541-545","source":"Crossref","is-referenced-by-count":6,"title":["Pyoderma Gangrenosum Successfully Treated with Cyclosporin A"],"prefix":"10.1007","author":[{"given":"M. T.","family":"V\u2019l\u010dkova-Laskoska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. S.","family":"Laskoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. G.","family":"Caca-Biljanovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Darkoska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"81_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1001\/archderm.1930.01440160053009","volume":"22","author":"LA Brunsting","year":"1930","unstructured":"Brunsting LA, Goeckerman WH, O\u2019Leary PA. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observations in five cases occuring in adults. Arch Dermatol 22:655\u2013680 (1930)","journal-title":"Arch Dermatol"},{"key":"81_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2133.1981.tb00048.x","volume":"104","author":"RR Jones","year":"1981","unstructured":"Jones RR: Cutaneous manifestations of paraproteinemia. Br J Dermatol. 104:209\u2013220 (1981)","journal-title":"Br J Dermatol"},{"key":"81_CR3","first-page":"722","volume-title":"Cyclosporine:Nature of the Agent and its Immunologic Actions","author":"JFI Borel","year":"1988","unstructured":"Borel JF. In: Kahan B, ed. Cyclosporine:Nature of the Agent and its Immunologic Actions. New York, NY:Guine and Stratton 722\u2013730 (1988)"},{"key":"81_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/1523-1747.ep12462009","volume":"90","author":"M Furue","year":"1988","unstructured":"Furue M, Gaspari A, Katz S. The effect of cyclosporin A on epidermal cells II: cyclosporin A inhibits proliferation of normal and transformed keratinocytes. J Invest Dermatol 90:796\u2013800 (1988).","journal-title":"J Invest Dermatol"},{"key":"81_CR5","first-page":"424","volume":"92","author":"G Elgart","year":"1989","unstructured":"Elgart G, Larson K, Stover P, Davis B. Effective treatment of pyoderma gangrenosum with cyclosporin: a report of five cases. J Invest Dermatol. 92:424 (1989)","journal-title":"J Invest Dermatol."},{"key":"81_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0190-9622(89)80063-5","volume":"20","author":"ML Magid","year":"1989","unstructured":"Magid ML, Gold MH. Treatment of recalcitrant pyoderma gangrenosum with cyclosporine. J Am Acad Dermatol. 20:293\u2013294 (1989).","journal-title":"J Am Acad Dermatol"},{"key":"81_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2133.1985.tb02385.x","volume":"113","author":"RK Curley","year":"1985","unstructured":"Curley RK, Mcfarlane AW, Vickers CFH. Pyoderma Gangrenosum treated with Cyclosporine. Br J Dermatol. 113:601\u2013604(1985).","journal-title":"Br J Dermatol"},{"key":"81_CR8","volume-title":"International Congress on Immunointervention","author":"VC Ho","year":"1996","unstructured":"Ho VC, Dutz J, Gulliver W, Lauzon G. Canadian experience of cyclosporin A (Sandimmun and Sandimmun Neoral) in the treatment of refractory pyoderma gangrenosum. International Congress on Immunointervention. The Role of Neoral in Immune-Based Diseases. Rome, Italy, June 1996 (Abstracts)"},{"key":"81_CR9","volume-title":"International Congress on Immunointervention","author":"NJ Mork","year":"1996","unstructured":"Mork NJ, Mork G, Koss-Harnes D. Severe pyoderma gangrenosum successfully treated with cyclosporin. International Congress on Immunointervention. The Role of Neoral in Immune-Based Diseases. Rome, Italy, June 1996 (Abstracts)"},{"key":"81_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1749-6632.1995.tb26661.x","volume":"766","author":"DZ Wang","year":"1995","unstructured":"Wang DZ, McCafrey PG, Rao A. The Cyclosporin-sensitive transcription factor NFATp is expressed in several classes of cells in the immune system. Ann New York Acad Sci 766:182\u2013194 (1995)","journal-title":"Ann New York Acad Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Rheumaderm"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-4857-7_81.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T11:37:13Z","timestamp":1619869033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-4857-7_81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9781461372035","9781461548577"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-4857-7_81","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1999]]}}}